发明名称 COMPOUNDS FOR ALZHEIMER'S DISEASE
摘要 The invention provides novel compounds useful for the treatment of neurodegenerative disorders including Alzheimer's disease and dementia. The compounds have a substituents chosen from -L-C(═O)OH, -L-CH═CHC(═O)OH, -L-C(═O)NH2, -L-C(═O)NH(C1-3 alkyl), -L-C(═O)N(C1-3 alkyl)2, -L-S(═O)2(C1-3alkyl), -L-S(═O)2NH2, -L-S(═O)2N(C1-3 alkyl)2, -L-S(═O)2NH(C1-3 alkyl), -L-C(═O)NHOH, -L-C(═O)CH2NH2, -L-C(═O)CH2OH, -L-C(═O)CH2SH, -L-C(═O)NHCN, -L-NHC(═O)ORo, -L-C(═O)NHRo, -L-NH(C═O)NHRo, -L-C(═O)N(Ro)2, -L-NH(C═O)N(Ro)2, -L-sulfo, -L-(2,6 difluorophenol), -L-phosphono, and -L-tetrazolyl, where L is a linker.
申请公布号 US2012225873(A1) 申请公布日期 2012.09.06
申请号 US201213447115 申请日期 2012.04.13
申请人 SLADE RACHEL;KLIMOVA YEVGENIYA;HALTER ROBERT J.;YUNGAI ASHANTAI J.;WEINER WARREN S.;WALTON RUTH J.;WILLARDSEN JON ADAM;ANDERSON MARK B.;ZAVITZ KENTON;MYREXIS, INC. 发明人 SLADE RACHEL;KLIMOVA YEVGENIYA;HALTER ROBERT J.;YUNGAI ASHANTAI J.;WEINER WARREN S.;WALTON RUTH J.;WILLARDSEN JON ADAM;ANDERSON MARK B.;ZAVITZ KENTON
分类号 A61K31/5377;A61K31/403;A61K31/404;A61K31/422;A61K31/437;A61K31/4439;A61K31/4985;A61K31/501;A61K31/5025;A61P25/28;C07D209/12;C07D209/18;C07D209/90;C07D401/04;C07D401/14;C07D403/10;C07D405/14;C07D413/04;C07D413/08;C07D413/10;C07D413/14;C07D417/04;C07D471/06;C07D491/10 主分类号 A61K31/5377
代理机构 代理人
主权项
地址